Aehr Test Systems (AEHR) concluded trading on Wednesday at a closing price of $16.93, with 3.13 million shares of worth about $52.96 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -67.36% during that period and On Wednesday, January 24 the price saw a gain of about 1.10%. Currently the company’s common shares owned by public are about 28.54M shares, out of which, 27.05M shares are available for trading.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 141 times over the past 12 months. They bought 629,487 shares in 60 of the transactions. In 81 selling transactions, insiders dumped 1,035,368 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Vanguard Total Stock Market ETF, iShares Russell 2000 ETF, and Congress Small Cap Growth Fund are the top 3 mutual funds which are holding stakes in Aehr Test Systems Vanguard Total Stock Market ETF is currently holding 0.89 million shares of worth totaling $23.51 million. The company recently came buying 0.0 shares which brought its stake up to 3.08% of the company’s outstanding shares. iShares Russell 2000 ETF sold 1944.0 shares, after which its hold over company’s outstanding shares shrunk to 2.56%, leaving 0.74 million shares with the mutual fund that have a worth of about $19.55 million. Congress Small Cap Growth Fund, after buying 0.65 million shares, have now control over 2.26% of the stake in the company. It holds 25000.0 shares of worth $17.24 million.
Stock saw a price change of -1.20% in past 5 days and over the past one month there was a price change of -40.22%. Year-to-date (YTD), AEHR shares are showing a performance of -36.17% which decreased to -50.86% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $16.21 but also hit the highest price of $54.10 during that period. The average intraday trading volume for Aehr Test Systems shares is 1.41 million. The stock is currently trading -21.93% below its 20-day simple moving average (SMA20), while that difference is down -29.32% for SMA50 and it goes to -51.58% lower than SMA200.
Aehr Test Systems (NASDAQ: AEHR) currently have 28.54M outstanding shares and institutions hold larger chunk of about 69.22% of that. Holding of mutual funds in the company is about — while other institutional holders and individual stake holders have control over — and — of the stake respectively.
The stock has a current market capitalization of $488.57M and its 3Y-monthly beta is at 2.02. PE ratio of stock for trailing 12 months is 23.87, while it has posted earnings per share of $0.71 in the same period. Its PEG reads 1.19 and has Quick Ratio of 7.28 while making debt-to-equity ratio of 0.07. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for AEHR, volatility over the week remained 6.21% while standing at 6.55% over the month.
Analysts are in expectations that Aehr Test Systems (AEHR) stock would likely to be making an EPS of $0.13 in the current quarter, while forecast for next quarter EPS is $0.23 and it is $1.37 for next year. For the current quarter EPS, analysts have given the company a lowest target $0.09 which is $0.17 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $0.16 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 29.66% while it is estimated to increase by 79.05% in next year. EPS is likely to shrink at an annualized rate of 20.00% for next 5-years, compared to annual growth of 90.24% made by the stock over the past 5-years.
